MedTach
Bringing Innovations to Canadian Clinicians and Researchers
  • Home
  • Updates
  • Covid-19
  • Products
    • Finapres Continuous Blood Pressure >
      • Hypertension Information
      • Finapres Nova - Products
      • Finapres Nova - Hardware >
        • Finapres Nova - Basic
        • Finapres Nova - ECG + RESP
        • Finapres Nova - Full Option
      • Finapres Nova - Software >
        • Guided Autonomic Testing (GAT)
        • Advanced Hemodynamics
        • Autonomic Testing
      • Finapres Nova - Application Fields >
        • Autonomic Failure Diagnosis >
          • Autonomic Failure Diagnosis
        • Hemodynamic Evaluation
        • Education with Finapres
        • Other Finapres Applications
      • Technologies - Finapres >
        • Volume-Clamp: Continuous BP Method
        • Nano Core Technology - Finapres
        • Height Correction Unit - Finapres
        • Physiocal Signal Quality Indicator - Finapres
        • Compare all Finapres Products
    • Butterfly IQ+ Whole-Body Ultrasound >
      • Butterfly iQ+ Specs >
        • IQ+ Compatibility
      • Ultrasound Education
      • TeleGuidance >
        • Compatible for Teleguidance
      • Butterfly Compare Membership Plans >
        • Butterfly iQ Pro Team
        • Butterfly Enterprise
    • Caretaker Wireless ICU Grade Vital Signs >
      • VitalStream
      • Caretaker News
      • Virtual Hospital Monitoring
      • Caretaker How To Use
    • TempTraq Body Temperature Patch >
      • TempTraq Clinical Benefits
      • TempTraq MedTach Contact Page
    • Bittium Cardiac Monitoring >
      • Faros Waterproof ECG
      • Cardiac Navigator Holter Analysis
      • HolterPlus Remote Cardiac Monitoring
      • Cardioscope Autonomic Testing
      • Cardiac Rehab
    • AliveCor >
      • KardiaMobile how to use
      • KardiaMobile
      • KardiaMobile 6L
    • PMD RespiraSense >
      • RespiraSense MedTach Contact Page
    • Kinesis Mobility & Fall Probability >
      • QTUG
      • Gait
      • Balance
    • Carrot Medical >
      • C-Com Wireless Headset
      • C-Suite
    • FIAB >
      • FIAB Eso Temp Monitor
      • FIAB Eso Leads
    • ProTech Radiation Protection >
      • Lead Glasses
      • Lead Caps
    • MPI >
      • MPI RRTilt Table
      • MPI Tilt Table
  • Telemedicine
  • Resources
    • ECG & HRV
    • Support >
      • Kinesis Setup & FAQ
      • Bittium Support
      • Finapres FAQ
  • Who We Are
    • Contact Us
  • Store
Contact us about RespiraSense
To All MedTach Solutions
MAKING EVERY BREATH COUNT
​Automated Respiratory Rate care for respiratory compromised patients in acute care
Picture
Revolutionizing Respiratory Outcomes

RespiraSense transforms the measurement of a patient’s Respiratory Rate with continuous, innovative, technology monitoring – improving the measurement and identification of deterioration, in a real-time manner to avoid preventable respiratory failure events helping save lives.
​RespiraSense
Piezoelectric continuous monitoring of Respiratory Rates algorithms run seamlessly to deliver reliable measurements where prompt meaningful interventions can be deployed.
RespiraSense​
Transmitting information through Bluetooth allows medical professionals to examine Respiratory Rate remotely with minimal contact with the patient.
Picture
Goldhill and colleagues reported that 21% of ward patients with a respiratory rate of 25-29 breaths/minute assessed by critical care outreach service die in hospital. These patients could have been identified as high risk up to 24 hours before the event with a specificity of over 95%.
Recent evidence suggests that an adult with a respiratory rate of over 20 breaths/minute is probably unwell, and an adult with a respiratory rate over 24 breaths/minute is likely to be critically ill.
80% of Manual Measurements are Incorrect
Clinical study in Beaumont Hospital, Ireland 2020: 3,910 hours of data demonstrated the same result to that of Badawy’s paper in 2017 with 36,955 data points across 6 hospitals: Electronically reported Respiratory Rate would have change the patients severity of condition in 41% of cases.   McCartan et al. DOI: 10.1088/1361-6579/ac05d5
Video of PMD Solutions RespiraSense and its use in Ireland with the HSE and the Digital Transformation Team, monitoring vital signs to deliver the Right Care to the Right Patient at the Right Time to Improve Outcomes. 
​RespiraSense predicts Hypoxia and Pyrexia 12hrs in advance in COVID patients
​RESPIRATORY FAILURE
General Wards, Post Surgical. Emergency, ICU Outreach, ...
41% admissions risk escalation, increase LoS, increase the cost of care [1]
COVID-19
​RespiraSense Continuous Respiratory Rate Monitoring gives medical professionals the confidence to know that future escalations in care can be prevented due to the continuous and non-invasive monitoring of patients’ respiratory rate while maintaining minimal patient contact.

​The RespiraSense sensor is an innovative, discrete wearable device ideally designed for COVID-19 patients who are at risk of adverse events. RespiraSense can monitor symptoms of COVID-19 such as shortness of breath and breathing difficulties. The remote monitoring of patients respiratory rate allows medical professionals to develop more accurate early warning scores all the while protecting hospital staff, allowing minimal contact, saving on PPE.
  • ​Respiratory rate > 27 BPM (Breaths per minute) is the most important predictor of Cardiac Arrest
  • 50% of patients with RR > 24 BPM suffer a serious adverse event
  • 21% of patients with 25 < RR< 29 BPM died
COPD
​Chronic Obstructive Pulmonary Disease (COPD) is the name of lung diseases including chronic bronchitis, emphysema and chronic obstructive airways disease where patients experience breathing difficulties. If a patient has COPD, the airways of their lungs become inflamed and narrowed. COPD is one of the most common causes of hospitalization. As air sacs become permanently damaged, it will become increasingly difficult to breathe in and out.

By using RespiraSense Continuous Respiratory Rate Monitoring allows medical professionals the confidence to know their patients progress. Any escalations in care can be prevented due to the continuous and non-invasive monitoring of the patients breathing preventing respiratory failure.
​
  • Respiratory rate > 20 Breaths Per Minute (BPM) is the most important predictor of Cardiac Arrest
  • 50% of patients with RR > 24 BPM suffer serious adverse events
  • 21% of patients with 25 < RR> 29 BPM died
Pneumonia
​Pneumonia is inflammation of the lungs, usually caused by an infection in lower respiratory tract. Respiratory techniques are commonly used to aid airway clearance and improve the rate of breathing. By using RespiraSense Continuous Respiratory Rate Monitoring allows medical professionals the confidence to know their patients progress. Any escalations in care can be prevented due to the continuous and non-invasive monitoring of the patients breathing preventing respiratory failure.
  • ​Respiratory rate > 20 Breaths Per Minute (BPM) is the most important predictor of Cardiac Arrest
  • 50% of patients with RR > 24 BPM suffer serious adverse events
  • 21% of patients with 25 < RR> 29 BPM died
Surgical
​Surgical procedures involving general or epidural anaesthetic can affect the patients breathing. Respiratory depression or failure can occur after a surgical procedure[5]., with RespiraSense’s continuous and motion tolerant monitoring of respiratory rate (cRR) can trigger timely and meaningful interventions 12 hours before the deterioration event
  • Respiratory rate > 20 Breaths Per Minute (BPM) is the most important predictor of Cardiac Arrest
  • 50% of patients with RR > 24 BPM suffer serious adverse events
  • 21% of patients with 25 < RR> 29 BPM died [3]
​An easy to use app allows multiple devices to be monitored continuously
Picture
Picture
​​​Accurate, real-time critical respiratory rate data
​SEPSIS

​​Sepsis is associated with 1 in 5 deaths globally. Lower respiratory infection is the most common underlying cause of sepsis-related complications and death.

​48.9 million cases of sepsis in 2017 and 11.0 million deaths. Two of every three cases occurred in patients with an underlying infectious condition; the remaining cases occurred in individuals with underlying injures or non-communicable diseases[4].
  • ​RR increases in advance of significant clinical events
  • Increased RR has a positive correlation to clinical invents of desaturation (<92%) and pyrexia (>38%)[2]
  • These increases were not detected by contemporaneous manual respiratory rate measurements
Population Screening – effortlessly increase patient coverage
​
SLEEP APNEA
Obstructive sleep apnea (OSA) is the most common sleep related breathing disorder and contributes to increased morbidity and compromised cardiovascular outcomes.
  • Respiration rate measured by chest and abdominal displacements
  • Position & activity level is recorded simultaneously
  • Apnea-Hypopnea Index (AHI) autoscoring with event by event reporting generated during the at home sleep study
  • Report uploaded to the cloud on the completion of home sleep test for immediate review
RespiraSense, the world’s first piezo electric continuous Respiratory Rate Monitor
​PMD’s novel sensor technology enables medical professionals to provide better patient care. The sensor directly measures the repetitive mechanical displacement of the chest and abdomen during breathing.
Feature 1
​Continuous Monitoring of Respiratory Rate ensures early deterioration from Sepsis
Feature 2
Provides confidence that escalations to ICU can be prevented
Feature 3
​Improves patient care and clinical outcomes with more accurate early warning scores
Picture
Contact us for more information about RespiraSense
MedTach Inc.
Head Office
​4145 North Service Rd., Suite 200
Burlington, Ontario, Canada L7L 6A3
1-289-644-4985 |
info@medtach.com


Copyright © 2023 MedTach. ​All Rights Reserved.
Contact Us